Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 14 studies | 53% ± 18% | |
| microglial cell | 12 studies | 34% ± 13% | |
| GABAergic neuron | 11 studies | 54% ± 26% | |
| glutamatergic neuron | 11 studies | 65% ± 23% | |
| endothelial cell | 9 studies | 30% ± 14% | |
| fibroblast | 7 studies | 28% ± 8% | |
| macrophage | 7 studies | 39% ± 15% | |
| retina horizontal cell | 6 studies | 48% ± 20% | |
| myeloid cell | 5 studies | 23% ± 4% | |
| pericyte | 5 studies | 20% ± 3% | |
| ciliated cell | 5 studies | 30% ± 12% | |
| type II pneumocyte | 5 studies | 27% ± 4% | |
| neuron | 4 studies | 42% ± 9% | |
| cardiac muscle cell | 4 studies | 26% ± 9% | |
| epithelial cell | 4 studies | 31% ± 17% | |
| monocyte | 4 studies | 18% ± 2% | |
| interneuron | 4 studies | 72% ± 22% | |
| GABAergic interneuron | 3 studies | 58% ± 20% | |
| adipocyte | 3 studies | 24% ± 4% | |
| retinal ganglion cell | 3 studies | 30% ± 12% | |
| lymphocyte | 3 studies | 17% ± 2% | |
| goblet cell | 3 studies | 41% ± 30% | |
| smooth muscle cell | 3 studies | 19% ± 3% | |
| granule cell | 3 studies | 36% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 2214.96 | 2567 / 2642 | 96% | 13.61 | 678 / 705 |
| kidney | 99% | 640.12 | 88 / 89 | 94% | 12.02 | 843 / 901 |
| pancreas | 99% | 645.76 | 326 / 328 | 89% | 6.12 | 159 / 178 |
| adrenal gland | 100% | 1429.48 | 258 / 258 | 87% | 8.29 | 201 / 230 |
| intestine | 100% | 1231.38 | 965 / 966 | 86% | 4.60 | 451 / 527 |
| stomach | 93% | 460.63 | 335 / 359 | 90% | 5.26 | 256 / 286 |
| skin | 97% | 611.43 | 1763 / 1809 | 82% | 5.69 | 386 / 472 |
| lung | 99% | 723.34 | 573 / 578 | 80% | 4.67 | 920 / 1155 |
| esophagus | 96% | 884.88 | 1380 / 1445 | 81% | 5.48 | 148 / 183 |
| thymus | 99% | 512.62 | 644 / 653 | 74% | 3.73 | 447 / 605 |
| breast | 100% | 816.96 | 459 / 459 | 72% | 3.72 | 801 / 1118 |
| prostate | 96% | 553.77 | 234 / 245 | 74% | 2.82 | 369 / 502 |
| liver | 97% | 535.57 | 220 / 226 | 59% | 2.77 | 238 / 406 |
| uterus | 100% | 969.68 | 170 / 170 | 49% | 2.15 | 225 / 459 |
| bladder | 100% | 1036.38 | 21 / 21 | 49% | 2.21 | 247 / 504 |
| ovary | 98% | 628.28 | 177 / 180 | 17% | 0.49 | 74 / 430 |
| adipose | 100% | 924.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 921.09 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 94% | 709.92 | 806 / 861 | 0% | 0 | 0 / 0 |
| spleen | 93% | 323.50 | 223 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 49% | 2.15 | 39 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 48% | 2.70 | 14 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 36% | 1.48 | 16 / 45 |
| peripheral blood | 20% | 98.52 | 187 / 929 | 0% | 0 | 0 / 0 |
| muscle | 16% | 56.81 | 130 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0015798 | Biological process | myo-inositol transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0150104 | Biological process | transport across blood-brain barrier |
| GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005769 | Cellular component | early endosome |
| GO_0005764 | Cellular component | lysosome |
| GO_0097450 | Cellular component | astrocyte end-foot |
| GO_0008021 | Cellular component | synaptic vesicle |
| GO_0071944 | Cellular component | cell periphery |
| GO_0030426 | Cellular component | growth cone |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0042995 | Cellular component | cell projection |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0044297 | Cellular component | cell body |
| GO_0031090 | Cellular component | organelle membrane |
| GO_0005366 | Molecular function | myo-inositol:proton symporter activity |
| GO_0002020 | Molecular function | protease binding |
| GO_0051117 | Molecular function | ATPase binding |
| GO_0005365 | Molecular function | myo-inositol transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC2A13 |
| Protein name | SLC2A13 protein Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13) Solute carrier family 2 member 13 |
| Synonyms | |
| Description | FUNCTION: H(+)-myo-inositol cotransporter . Can also transport related stereoisomers . . |
| Accessions | ENST00000280871.9 Q86X07 ENST00000380858.1 E9PE47 Q96QE2 |